[Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
D000553:Ambulatory Care; D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D014042:Tolazamide / Q000009:adverse effects / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D014508:Urea; D002784:Cholesterol; D014042:Tolazamide
Ergebnisse der oralen Behandlung des Diabetes mellitus mit dem neuen Sulfonylharnstoff Tolazamid unter Ambulanz-Bedingungen.